Medical & Therapeutic

Clinical Trial Transcription — FDA GCP, 21 CFR Part 11, Pharma-Industry-Grade

Clinical Trial Transcription Services

99%+ Accuracy
Two-stage human review
24-Hour Rush
Standard 3–5 day options
NDA Protected
Every transcriber signs
Human Reviewed
No machine-only output

Clinical trials operate under the most regulated framework in healthcare. FDA Good Clinical Practice (GCP) governs investigator conduct. 21 CFR Part 11 governs electronic records and signatures. HIPAA governs PHI handling. The Common Rule governs human subjects research. ICH-GCP standards govern international trials. Every transcription decision must satisfy this convergent regulatory framework or risk study integrity, FDA findings, sponsor audit response, and ultimately drug approval.

VerbalScripts produces clinical trial transcription for pharmaceutical sponsors, contract research organizations (CROs), clinical investigators, and FDA-regulated medical device manufacturers. FDA GCP compliance. 21 CFR Part 11 electronic records compliance. Signed HIPAA BAA. Investigator meeting documentation. Multi-site coordination. Pharmaceutical industry-grade audit trails. Capacity for multi-year trial cycles.

Our clinical trial transcription engagements are built on six commitments: certified accuracy supporting the evidentiary, regulatory, or operational use of your transcripts; SOC 2 Type II audited infrastructure with encryption in transit (TLS 1.2+) and at rest (AES-256); U.S.-based specialty transcribers as default with single-transcriber assignment available for sensitive matters; medical-specific NDAs with confidentiality matching the gravity of your work; configurable retention with certified deletion; and zero AI training on customer audio — a written contractual commitment, not a marketing line.

Built For You

Why Choose VerbalScripts

Clinical trial transcription requires: FDA Good Clinical Practice (GCP) compliance, 21 CFR Part 11 electronic records and signatures compliance with audit trails, HIPAA Security Rule-aligned infrastructure with signed BAA, ICH-GCP awareness for international trials, sponsor audit-defensible documentation, multi-site coordination across study sites, capacity scaling for multi-year trial timelines.

Our service delivers all of these. FDA GCP-compliant workflow. 21 CFR Part 11 electronic records with immutable audit trails. HIPAA BAA. ICH-GCP support. Sponsor audit-defensible documentation. Multi-site coordination with consistent format. Multi-year capacity. Single-transcriber assignment for sponsor-blind material.

Clinical Trial transcription is not a commodity. The difference between a vendor that delivers accurate, format-compliant, audit-defensible output and a vendor that delivers something close to that but not quite right shows up in motion practice, regulatory examination, audit response, edit room rework, IR portal posting, and the operational cycles where transcripts are actually used. VerbalScripts is built for the version that holds up.

Use Cases

Common Use Cases for Clinical Trial

Clinical Trial Transcription professionals use our service across every stage of their work.

01

Clinical Investigator Meeting Documentation

Investigator meeting transcription for protocol training, safety updates, and study coordination with GCP compliance and sponsor audit support.

02

FDA Advisory Committee Meeting Documentation

FDA advisory committee meeting documentation with regulatory format and public disclosure considerations. Our clinical trial specialty team handles this category with appropriate format, vocabulary accuracy, and operational rigor — supported by audit logs, configurable retention, and the security posture your procurement process expects.

03

Clinical Trial Site Coordination Meetings

Multi-site clinical trial coordination meetings with consistent format across sites and sponsor reporting. Our clinical trial specialty team handles this category with appropriate format, vocabulary accuracy, and operational rigor — supported by audit logs, configurable retention, and the security posture your procurement process expects.

04

Patient Recruitment and Informed Consent

Patient recruitment interviews and informed consent process documentation with HIPAA workflow and IRB compliance. Our clinical trial specialty team handles this category with appropriate format, vocabulary accuracy, and operational rigor — supported by audit logs, configurable retention, and the security posture your procurement process expects.

05

Clinical Endpoint Adjudication

Clinical endpoint adjudication committee meetings with blinded review documentation and adjudication committee format. Our clinical trial specialty team handles this category with appropriate format, vocabulary accuracy, and operational rigor — supported by audit logs, configurable retention, and the security posture your procurement process expects.

06

Pharmacovigilance and Safety Reviews

Pharmacovigilance committee meetings, DSMB meetings, safety review documentation with FDA reporting awareness. Our clinical trial specialty team handles this category with appropriate format, vocabulary accuracy, and operational rigor — supported by audit logs, configurable retention, and the security posture your procurement process expects.

07

Clinical Trial Audit and Inspection Preparation

Clinical trial audit preparation documentation and FDA inspection readiness materials. Our clinical trial specialty team handles this category with appropriate format, vocabulary accuracy, and operational rigor — supported by audit logs, configurable retention, and the security posture your procurement process expects.

08

Multi-Site International Trial Coordination

ICH-GCP-aligned international clinical trial coordination with multilingual native-speaker capability across study sites. Our clinical trial specialty team handles this category with appropriate format, vocabulary accuracy, and operational rigor — supported by audit logs, configurable retention, and the security posture your procurement process expects.

Challenges We Solve

Key Challenges We Solve

Clinical Trial transcription presents specific challenges that generic vendors fail. The challenges below are the ones our specialty teams encounter regularly — and that drive the design decisions in our service architecture. Each represents a failure mode we have built explicitly against.

FDA GCP complianceClinical trial transcription operates under FDA Good Clinical Practice. Generic vendors fail GCP. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

21 CFR Part 11 electronic recordsFDA-regulated electronic records require Part 11 compliance with audit trails. Generic vendors lack Part 11 alignment. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

HIPAA BAA for PHI handlingClinical trials contain PHI requiring HIPAA Business Associate Agreement. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

ICH-GCP for international trialsInternational clinical trials require ICH-GCP awareness. Generic vendors do not understand ICH framework. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

Sponsor audit defensibilityClinical trial documentation faces sponsor audits, FDA inspection, and regulatory examination requiring audit-defensible practices. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

Multi-site coordinationMulti-site trials require consistent format across study sites and sponsor reporting framework. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

Multi-year trial capacityPhase III clinical trials run multi-year requiring capacity scaling and team consistency. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

Pharmaceutical industry confidentialityPre-approval drug development includes intellectual property requiring pharmaceutical industry-grade confidentiality. Our service is built explicitly against this failure mode. The architecture, transcriber training, quality review process, and delivery format all reflect the specific requirements of work.

What You Get

What You Get with VerbalScripts

Features built into every clinical trial transcription engagement. These are not add-ons or premium-tier capabilities — they are standard across our service for this category. The architecture reflects what medical practitioners actually need rather than what generic transcription vendors typically offer.

FDA GCP-Compliant Workflow

Good Clinical Practice compliance for clinical trial transcription with documented adherence. This is standard across our clinical trial engagements — not an upsell or premium-tier capability. The operational reality of work demanded it, and our service architecture reflects that.

21 CFR Part 11 Electronic Records

Electronic records and signatures compliance with immutable audit trails for FDA inspection. This is standard across our clinical trial engagements — not an upsell or premium-tier capability. The operational reality of work demanded it, and our service architecture reflects that.

HIPAA BAA Standard

Signed Business Associate Agreement with HIPAA Security Rule-aligned infrastructure. This is standard across our clinical trial engagements — not an upsell or premium-tier capability. The operational reality of work demanded it, and our service architecture reflects that.

ICH-GCP for International Trials

ICH-GCP awareness for international clinical trial coordination. This is standard across our clinical trial engagements — not an upsell or premium-tier capability. The operational reality of work demanded it, and our service architecture reflects that.

Sponsor Audit Defensibility

Audit-defensible documentation supporting sponsor audit, FDA inspection, regulatory examination. This is standard across our clinical trial engagements — not an upsell or premium-tier capability. The operational reality of work demanded it, and our service architecture reflects that.

Multi-Site Coordination

Consistent format across multi-site studies with sponsor reporting framework support. This is standard across our clinical trial engagements — not an upsell or premium-tier capability. The operational reality of work demanded it, and our service architecture reflects that.

Multi-Year Trial Capacity

Capacity scaling for Phase III multi-year trials with dedicated team continuity. This is standard across our clinical trial engagements — not an upsell or premium-tier capability. The operational reality of work demanded it, and our service architecture reflects that.

Security & Privacy

FDA & Pharmaceutical Industry Compliance Framework

Clinical trial transcription operates under FDA GCP (21 CFR Parts 50, 54, 56), 21 CFR Part 11 for electronic records and signatures, HIPAA Privacy and Security Rules, Common Rule for human subjects research, ICH-GCP for international trials, FDA medical device regulations, pharmaceutical industry codes of conduct.

Our compliance posture is designed for procurement defensibility. We provide written documentation of our security architecture, retention practices, sub-processor arrangements, audit log practices, and breach notification commitments. Vendor risk assessments are supported with SOC 2 Type II reports under NDA, completed security questionnaires (SIG, CAIQ, custom), and direct conversation with our security team when your procurement process requires it.

  • FDA GCP — 21 CFR Parts 50 (informed consent), 54 (financial disclosure), 56 (IRB)
  • 21 CFR Part 11 — electronic records and signatures with audit trails
  • HIPAA Privacy and Security Rules — PHI handling for clinical trial PHI
  • Common Rule (45 CFR 46) — human subjects research
  • ICH-GCP — International Conference on Harmonisation Good Clinical Practice
  • FDA medical device regulations (21 CFR Parts 820, 821)
  • Pharmaceutical industry codes of conduct (PhRMA, IFPMA)
  • Multi-site coordination across study sites
  • Sponsor audit-defensible documentation
  • Single-transcriber assignment for sponsor-blind material
  • Immutable audit trails for FDA inspection
  • Configurable retention supporting GCP record retention requirements
  • Zero AI training on clinical trial material — written contractual commitment

Our Process

How It Works: Our Six-Step Process

1

Engagement Setup & Onboarding

Open clinical trial engagement with signed HIPAA BAA, FDA GCP-compliant workflow setup, 21 CFR Part 11 electronic records configuration, sponsor audit requirements, multi-site coordination parameters. Onboarding typically completes within 24 hours for standard engagements; complex multi-stakeholder engagements may take 48-72 hours. Your dedicated account team confirms format defaults, integration parameters, retention preferences, and any specialty requirements before first upload.

2

Encrypted Upload & Intake

Upload clinical trial audio through encrypted portal or sponsor-approved electronic data capture (EDC) integration. All uploads use TLS 1.2+ with AES-256 at rest and 21 CFR Part 11-compliant audit trails. All uploads use TLS 1.2+ in transit. At rest, audio and transcript data are encrypted with AES-256. Your encrypted portal supports drag-and-drop, bulk upload, and direct integration with practice management, claims platforms, research repositories, conference platforms, or other workflow tools depending on your category.

3

Specialty Routing & Assignment

Audio routed to clinical research specialty transcribers with pharmaceutical industry experience, GCP training, and single-transcriber assignment for sponsor-blind material. Our routing engine matches audio to specialty transcribers based on domain, language, security clearance, and complexity profile. Single-transcriber assignment is available for sensitive matters. For multi-day, multi-session, or longitudinal projects, dedicated team continuity is the default to preserve methodological consistency and vocabulary handling.

4

Specialty Transcription with Domain Vocabulary

Clinical trial specialty transcription with FDA GCP-compliant workflow, 21 CFR Part 11 audit trails, HIPAA BAA, ICH-GCP awareness for international trials, sponsor audit-defensible documentation. Transcribers work within structured quality protocols including style guide adherence, vocabulary verification against your provided terminology lists, time-stamping per your specification, and speaker disambiguation per the conventions of your category.

5

Senior Review & Quality Assurance

Senior clinical research reviewer with pharmaceutical industry background verifies GCP compliance, Part 11 audit trail integrity, HIPAA compliance, sponsor reporting format, multi-site consistency. Our two-pass review process includes specialty review by a senior transcriber and quality assurance review by a quality manager. Both passes are documented in immutable audit logs supporting evidentiary defensibility, regulatory examination, or audit response when applicable to your category.

6

Format-Compliant Delivery & Retention

Sponsor- and FDA-defensible delivery with 21 CFR Part 11 audit trails, HIPAA-compliant retention per GCP record retention requirements (typically 15+ years post-study closeout), certified deletion supporting GCP retention with attestation. Deliverables are returned via your specified channel — portal download, email, SFTP, or direct integration with your workflow platform. Audit logs are retained per your category's regulatory expectations. Source audio retention is configurable from 7 days to multi-year per your governance requirements, with certified deletion at end-of-retention.

Quality Assured

Accuracy, Security, and Confidentiality

Clinical trial material represents pharmaceutical industry IP and PHI under the most regulated framework in healthcare. SOC 2 Type II audited, signed HIPAA BAA, U.S.-only personnel default with single-transcriber assignment for sponsor-blind material, 21 CFR Part 11 immutable audit trails, configurable retention per GCP requirements, certified deletion with attestation, ICH-GCP compliance for international trials, pharmaceutical industry-grade confidentiality matching sponsor expectations.

Our security architecture supports vendor due diligence at the highest level. SOC 2 Type II audited operations with reports available under NDA. Encryption in transit (TLS 1.2 minimum) and at rest (AES-256). U.S.-based specialty transcribers as default with single-transcriber assignment for sensitive matters. Signed medical-specific NDAs covering the confidentiality conventions and regulatory frameworks of your work. Role-based access with per-engagement, per-matter, or per-project separation depending on your category's operational structure. Immutable audit logs supporting evidentiary defensibility, regulatory examination, audit response, and incident investigation when applicable.

We do not use customer audio to train AI models — this is a written contractual commitment, not a marketing line. Retention is configurable per your governance requirements: 7 days for ephemeral material, 30/60/90 days for standard, multi-year for material under legal hold or regulatory retention obligations, with certified deletion at end-of-retention. Sub-processor arrangements are documented and available under NDA for your vendor risk assessment.

Pricing & Turnaround

Turnaround Times and Pricing

Per-audio-minute pricing with medical-friendly subscription tiers for active practice. Pricing reflects the operational reality of your work — not generic vendor rate cards. Subscription tiers provide volume-discounted rates with predictable monthly cost structure, dedicated account team, and SLA commitments aligned to your operational cycles.

Turnaround Option
Best For
Standard (3 business days)
Routine clinical trial work — typical engagements with standard complexity and no special timing requirements
Expedited (48 hours)
Deadline-sensitive clinical trial matters — motion practice, regulatory deadlines, editorial cycles, IR posting, claim cycle compliance
Rush (24 hours)
Urgent clinical trial timing — same-week court deadlines, regulatory examination response, breaking news, time-sensitive operational use
Same-Day Rush (4-8 hours)
Imminent clinical trial deadlines — same-day court use, post-event publication, post-meeting distribution, emergency operational support
Subscription
Active medical practice with consolidated billing, dedicated account team, volume-discounted rates, and predictable monthly cost structure

Per-audio-minute pricing with clinical trial-specific format included as standard — not as add-on. Subscription tier provides 30% savings for active practice with consolidated billing. Add-ons available where genuinely needed: multilingual native-speaker transcription, certified translation, notarized certificate of accuracy, specialty certifications, and custom integration. Volume pricing available for enterprise and high-volume engagements. Quote upon consultation for non-standard requirements.

Industry Insights

Industry Insights

01

FDA receives over 30,000 IND applications and 3,000 NDA/BLA submissions annually with substantial clinical trial documentation underlying submissions.

02

Phase III clinical trial costs have grown to hundreds of millions per program with corresponding sponsor investment in audit-defensible documentation.

03

FDA inspection findings related to documentation have remained a significant cause of warning letters and 483 observations.

04

21 CFR Part 11 enforcement has remained substantial with pharmaceutical industry investment in compliant systems.

05

ICH-GCP harmonization has matured with international clinical trial coordination across regions.

06

Pharmacovigilance has expanded with post-market safety requirements driving ongoing transcription demand.

07

Decentralized and hybrid clinical trials have grown with corresponding telehealth and remote consent transcription demand.

08

Pharmaceutical industry consolidation has increased with multi-program sponsor transcription procurement.

Client Testimonial

What Our Clients Say

I'm a clinical research director at a CRO. VerbalScripts handles our clinical trial transcription with FDA GCP compliance, 21 CFR Part 11 audit trails, HIPAA BAA, multi-site coordination across our Phase III programs. Our sponsor audit defensibility has improved substantially and our FDA inspection readiness is solid.

— Director Clinical Research, Contract Research Organization (CRO)

Got Questions?

Frequently Asked Questions

Q01.Are you FDA GCP-compliant?
Yes. FDA Good Clinical Practice-compliant workflow for clinical trial transcription with documented adherence supporting sponsor audit and FDA inspection.
Q02.Do you support 21 CFR Part 11?
Yes. 21 CFR Part 11 electronic records and signatures compliance with immutable audit trails for FDA inspection readiness.
Q03.Will you sign a HIPAA BAA?
Yes. Signed HIPAA Business Associate Agreement standard for clinical trial transcription involving PHI.
Q04.Do you support ICH-GCP for international trials?
Yes. ICH-GCP awareness for international clinical trial coordination across regions.
Q05.Can you handle multi-site clinical trials?
Yes. Multi-site clinical trial coordination with consistent format across study sites and sponsor reporting framework.
Q06.Do you support pharmacovigilance and DSMB?
Yes. Pharmacovigilance committee meetings, DSMB meetings, safety review documentation with FDA reporting awareness.
Q07.Are you ready for FDA inspection?
Yes. Documentation practices designed for FDA inspection readiness with 21 CFR Part 11 audit trails and sponsor audit defensibility.
Q08.How do you handle sponsor-blind material?
Single-transcriber assignment for sponsor-blind material with appropriate confidentiality.
Q09.What is your retention?
Configurable retention supporting GCP record retention requirements (typically 15+ years post-study closeout) with certified deletion at end-of-retention.
Q10.Do you use my clinical trial material to train AI?
No. Written contractual commitment never to use clinical trial material for AI training. Pharmaceutical IP and PHI protection are paramount.
Start Today

FDA-GCP-Compliant. 21-CFR-Part-11-Audited. HIPAA-BAA-Standard. Pharma-Industry-Grade.

Schedule your clinical research consultation today. Signed HIPAA BAA and FDA GCP-compliant workflow on engagement opening.

No credit card requiredFree sample available24-hour delivery